黑料网

ISSN: 2332-0877

Journal of Infectious Diseases & Therapy
黑料网

Our Group organises 3000+ Global Events every year across USA, Europe & Asia with support from 1000 more scientific Societies and Publishes 700+ 黑料网 Journals which contains over 50000 eminent personalities, reputed scientists as editorial board members.

黑料网 Journals gaining more Readers and Citations
700 Journals and 15,000,000 Readers Each Journal is getting 25,000+ Readers

This Readership is 10 times more when compared to other Subscription Journals (Source: Google Analytics)

Mesenchymal stem cell as a cure for brain damage induced by chronic Toxocara canis infection in an experimental mouse model

6th Annual Conference on Parasitology & Infectious Diseases

Fatma Hamed Shalan, Ayman Abd El-Moenem Elbadry, Amera Fathy Afifi, Engy Victor Nassief Beshay, Samar Ahmed El-Refai, Hala Gabr Metwaly,Eman Ahmedy, Eman Abd El-Fattah Badr, Dalia Refaat Al-Sharaky and Gehan Salah Sadek

Parasitology Department, Faculty of Medicine, Menoufia University, EgyptParasitology Department, Faculty of Medicine, Cairo University, EgyptClinical Pathology Department, Faculty of Medicine, Cairo University, EgyptClinical Pathology Department, Faculty of Medicine, Menoufia University, EgyptBiochemistry Department, Faculty of Medicine, Menoufia University, EgyptPathology Department, Faculty of Medicine, Menoufia University, Egypt

ScientificTracks Abstracts: J Infect Dis Ther

DOI:

Abstract
Neurotoxocariasis is a serious condition linked to the reduced cognitive function in children and some neurodegenerative diseases. Unfortunately, the available drugs for its treatment are with variable results. Mesenchymal stem cells (MSCs) have been used in experimental and clinical trials and it gave promising therapeutic results. Therefore, this study was designed using forty T. canis-infected albino mice (1000 eggs/mouse, orally) and a control group (GI) of ten healthy mice. The infected groups were GII: infected non-treated (control group), GIII: albendazole-treated (100 mg/kg/d once orally for 5 successive days), GIV: MSCs-treated (3 x 106 MSCs in 0.1 mL of PBS via the tail vein) and GV: albendazole + MSCs-treated. Treatment was commenced 6 weeks p.i. and the experiment was terminated four weeks after treatment. The brain tissue of each mouse was subjected for histopathological, immunohistochemical studies (caspase-3, TGF-尾), detection or T. canis DNA by real-time PCR and gene expression the biomarkers of brain damage (S100B, GFAP) by RT-PCR. Moreover, homing of iron oxide-labelled MSCs in brain tissues was assessed by Prussian blue stain. The brain tissues of GII showed numerous T. canis larvae, significant congestion, thickening of arterioles, inflammatory infiltrate and gliosis associated with marked immunohistochemical expression of TGF-尾 and caspase-3 as well as marked S100B and GFAP gene expression. Significant improvements of the previous parameters and T. canis DNA were recorded in all the treated groups. However, the best results were obtained with combined albendazole + MSCs therapy. Thus, MSCs could be considered in the treatment of chronic neurotoxocariasis.
Biography

Fatma shalan has completed her bachelor of medicine with excellent grade in 2006 from Faculty of Medicine, Menofia University. She has completed her M.Sc. in Medical Parasitology in 2012. Her thesis was about the relationship between IL-6 and some parasitic infections in hepatic patients in Menofia governorate. This abstract is representative of her M.D. thesis.

E-mail: dr.fatma.shaalan@gmail.com

 

International Conferences 2024-25
 
Meet Inspiring Speakers and Experts at our 3000+ Global

Conferences by Country

Medical & Clinical Conferences

Conferences By Subject

Top